vs

Side-by-side financial comparison of Natera, Inc. (NTRA) and Rollins, Inc. (ROL). Click either name above to swap in a different company.

Rollins, Inc. is the larger business by last-quarter revenue ($906.4M vs $665.5M, roughly 1.4× Natera, Inc.). Rollins, Inc. runs the higher net margin — 11.9% vs 7.1%, a 4.8% gap on every dollar of revenue. On growth, Natera, Inc. posted the faster year-over-year revenue change (39.8% vs 10.2%). Rollins, Inc. produced more free cash flow last quarter ($111.2M vs $37.8M). Over the past eight quarters, Natera, Inc.'s revenue compounded faster (34.5% CAGR vs 0.8%).

Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendment...

Rollins, Inc. is a North American pest control company serving residential and commercial clients. Operating globally through its wholly owned subsidiaries, Orkin, Inc., PCO Services, HomeTeam Pest Defense, Western Pest Services, Industrial Fumigant Company, TruTech, Critter Control, Crane, Waltham, OPC Services, PermaTreat, Northwest Exterminating, McCall Service and Clark Pest Control, as well UK subsidiaries Integrated Pest Management Limited, Safeguard Pest Control, NBC Environment, Europ...

NTRA vs ROL — Head-to-Head

Bigger by revenue
ROL
ROL
1.4× larger
ROL
$906.4M
$665.5M
NTRA
Growing faster (revenue YoY)
NTRA
NTRA
+29.6% gap
NTRA
39.8%
10.2%
ROL
Higher net margin
ROL
ROL
4.8% more per $
ROL
11.9%
7.1%
NTRA
More free cash flow
ROL
ROL
$73.4M more FCF
ROL
$111.2M
$37.8M
NTRA
Faster 2-yr revenue CAGR
NTRA
NTRA
Annualised
NTRA
34.5%
0.8%
ROL

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
NTRA
NTRA
ROL
ROL
Revenue
$665.5M
$906.4M
Net Profit
$47.3M
$107.8M
Gross Margin
Operating Margin
-3.4%
16.1%
Net Margin
7.1%
11.9%
Revenue YoY
39.8%
10.2%
Net Profit YoY
187.9%
2.5%
EPS (diluted)
$0.36
$0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NTRA
NTRA
ROL
ROL
Q1 26
$906.4M
Q4 25
$665.5M
$912.9M
Q3 25
$592.2M
$1.0B
Q2 25
$546.6M
$999.5M
Q1 25
$501.8M
$822.5M
Q4 24
$476.1M
$832.2M
Q3 24
$439.8M
$916.3M
Q2 24
$413.4M
$891.9M
Net Profit
NTRA
NTRA
ROL
ROL
Q1 26
$107.8M
Q4 25
$47.3M
$116.4M
Q3 25
$-87.5M
$163.5M
Q2 25
$-100.9M
$141.5M
Q1 25
$-66.9M
$105.2M
Q4 24
$-53.8M
$105.7M
Q3 24
$-31.6M
$136.9M
Q2 24
$-37.5M
$129.4M
Operating Margin
NTRA
NTRA
ROL
ROL
Q1 26
16.1%
Q4 25
-3.4%
17.5%
Q3 25
-16.5%
21.9%
Q2 25
-20.2%
19.8%
Q1 25
-15.8%
17.3%
Q4 24
-13.6%
18.1%
Q3 24
-8.9%
20.9%
Q2 24
-10.6%
20.4%
Net Margin
NTRA
NTRA
ROL
ROL
Q1 26
11.9%
Q4 25
7.1%
12.8%
Q3 25
-14.8%
15.9%
Q2 25
-18.5%
14.2%
Q1 25
-13.3%
12.8%
Q4 24
-11.3%
12.7%
Q3 24
-7.2%
14.9%
Q2 24
-9.1%
14.5%
EPS (diluted)
NTRA
NTRA
ROL
ROL
Q1 26
$0.22
Q4 25
$0.36
$0.24
Q3 25
$-0.64
$0.34
Q2 25
$-0.74
$0.29
Q1 25
$-0.50
$0.22
Q4 24
$-0.41
$0.22
Q3 24
$-0.26
$0.28
Q2 24
$-0.30
$0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NTRA
NTRA
ROL
ROL
Cash + ST InvestmentsLiquidity on hand
$116.5M
Total DebtLower is stronger
$650.6M
Stockholders' EquityBook value
$1.7B
$1.4B
Total Assets
$2.4B
$3.2B
Debt / EquityLower = less leverage
0.47×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NTRA
NTRA
ROL
ROL
Q1 26
$116.5M
Q4 25
$100.0M
Q3 25
$1.0M
$127.4M
Q2 25
$16.0M
$123.0M
Q1 25
$17.8M
$201.2M
Q4 24
$22.7M
$89.6M
Q3 24
$29.5M
$95.3M
Q2 24
$90.3M
$106.7M
Total Debt
NTRA
NTRA
ROL
ROL
Q1 26
$650.6M
Q4 25
$486.1M
Q3 25
$485.7M
Q2 25
$485.3M
Q1 25
$485.5M
Q4 24
$395.3M
Q3 24
Q2 24
Stockholders' Equity
NTRA
NTRA
ROL
ROL
Q1 26
$1.4B
Q4 25
$1.7B
$1.4B
Q3 25
$1.3B
$1.5B
Q2 25
$1.2B
$1.4B
Q1 25
$1.2B
$1.4B
Q4 24
$1.2B
$1.3B
Q3 24
$878.5M
$1.3B
Q2 24
$836.5M
$1.2B
Total Assets
NTRA
NTRA
ROL
ROL
Q1 26
$3.2B
Q4 25
$2.4B
$3.1B
Q3 25
$1.8B
$3.2B
Q2 25
$1.8B
$3.2B
Q1 25
$1.7B
$2.9B
Q4 24
$1.7B
$2.8B
Q3 24
$1.6B
$2.8B
Q2 24
$1.5B
$2.8B
Debt / Equity
NTRA
NTRA
ROL
ROL
Q1 26
0.47×
Q4 25
0.35×
Q3 25
0.32×
Q2 25
0.34×
Q1 25
0.36×
Q4 24
0.30×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NTRA
NTRA
ROL
ROL
Operating Cash FlowLast quarter
$73.9M
$118.4M
Free Cash FlowOCF − Capex
$37.8M
$111.2M
FCF MarginFCF / Revenue
5.7%
12.3%
Capex IntensityCapex / Revenue
5.4%
0.8%
Cash ConversionOCF / Net Profit
1.56×
1.10×
TTM Free Cash FlowTrailing 4 quarters
$109.1M
$621.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NTRA
NTRA
ROL
ROL
Q1 26
$118.4M
Q4 25
$73.9M
$164.7M
Q3 25
$59.4M
$191.3M
Q2 25
$37.6M
$175.1M
Q1 25
$44.5M
$146.9M
Q4 24
$52.9M
$188.2M
Q3 24
$51.8M
$146.9M
Q2 24
$4.0M
$145.1M
Free Cash Flow
NTRA
NTRA
ROL
ROL
Q1 26
$111.2M
Q4 25
$37.8M
$159.0M
Q3 25
$37.0M
$182.8M
Q2 25
$11.7M
$168.0M
Q1 25
$22.6M
$140.1M
Q4 24
$34.8M
$184.0M
Q3 24
$35.5M
$139.4M
Q2 24
$-7.7M
$136.4M
FCF Margin
NTRA
NTRA
ROL
ROL
Q1 26
12.3%
Q4 25
5.7%
17.4%
Q3 25
6.2%
17.8%
Q2 25
2.1%
16.8%
Q1 25
4.5%
17.0%
Q4 24
7.3%
22.1%
Q3 24
8.1%
15.2%
Q2 24
-1.9%
15.3%
Capex Intensity
NTRA
NTRA
ROL
ROL
Q1 26
0.8%
Q4 25
5.4%
0.6%
Q3 25
3.8%
0.8%
Q2 25
4.7%
0.7%
Q1 25
4.3%
0.8%
Q4 24
3.8%
0.5%
Q3 24
3.7%
0.8%
Q2 24
2.8%
1.0%
Cash Conversion
NTRA
NTRA
ROL
ROL
Q1 26
1.10×
Q4 25
1.56×
1.41×
Q3 25
1.17×
Q2 25
1.24×
Q1 25
1.40×
Q4 24
1.78×
Q3 24
1.07×
Q2 24
1.12×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons